Johnson & Johnson mentioned on Thursday {that a} real-world research confirmed that its single-shot COVID-19 vaccine protects towards profitable an infection and hospitalization for as much as six months.
The research, sponsored by the vaccine developer, was performed between January 1 and September 7 final yr, earlier than the Omicron variant was found.
This too is but to be reviewed.
J&J mentioned that safety towards an infection from its single-dose vaccine begins to say no solely by the fourth month, in comparison with the second month within the case of two-dose vaccines from rivals Pfizer Inc. and BioNTech in addition to Moderna.
J&J mentioned no deficiencies in safety have been discovered for admission to the ICU for all three vaccines.
The firm mentioned the research was performed by amassing claims and laboratory knowledge protecting 168 million individuals.
,
With inputs from TheIndianEXPRESS
